A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia
Clinical trial NCT04659122 · TERMINATED
Trial details
- NCT number
- NCT04659122
- Sponsor
- Airway Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-17
- Primary completion
- 2023-02-23
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.